Results for physiologically translation from French to English

use in physiologically based pharmacokinetic models, toxicol.
use in physiologically based pharmacokinetic models.

development of a physiologically based pharmacokinetic model for chloroform, toxicol.
development of a physiologically based pharmacokinetic model for chloroform.

a physiologically based description of ethylene oxide dosimetry in the rat, toxicol.
a physiologically based description of ethylene oxide dosimetry in the rat.

physiologically based pharmacokinetic modeling of inhaled 2-butoxyethanol in man, toxicol.
physiologically based pharmacokinetic modeling of inhaled 2-butoxyethanol in man.

a physiologically based dosimetry description of acrylonitrile and cyanoethylene oxide in the rat, toxicol.
role of human cytochrome p-450 iie1 in the oxidation of many low molecular weight cancer suspects.

physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapour by humans, fundam.
physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapour by humans.

o’flaherty, e.j. «physiologically based models for bone-seeking elements.
phytotoxicity section, air resources branch, toronto, ontario.

estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling, toxicol.
estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling.

identification of the physiologically important transporters for cholesterol efflux: in vivo reverse cholesterol transport (rct)
role of the autonomic nervous system and renin angiotensin system in chronic aortic valve regurgitation

physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans, toxicol.
physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans.

reitz, r.h. et andersen, m.e. physiologically-based pharmacokinetics and the risk assessment process for methylene chloride.
reitz, r.h. and andersen, m.e. physiologically-based pharmacokinetics and the risk assessment process for methylene chloride.

«physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans», toxicol.
a wiley-interscience publication, john wiley & sons, new york, new york: 686-693.

53-57, dans m.e. andersen, h.j. clewell, m.l. gargas, e.a. smith et r.h. reitz, «physiologically based pharmacokinetics and the risk assessment process for methylene chloride», toxicol.
physiologically based pharmacokinetics and the risk assessment process for methylene chloride.